National Statistics

MRSA, MSSA and Gram-negative bacteraemia and CDI: annual report

Trends in MRSA, MSSA, E. coli, Klebsiella spp. and P. aeruginosa bacteraemia and C. difficile infection by financial year.

Documents

Details

The following financial year data is included in the latest annual epidemiological commentary for meticillin resistant Staphylococcus aureus (MRSA), meticillin susceptible Staphylococcus aureus (MSSA), Escherichia coli (E. coli), Klebsiella species (Klebsiella spp.) and Pseudomonas aeruginosa (P. aeruginosa) bacteraemia and Clostridioides difficile infection (CDI).

From July 2018:

  • MRSA bacteraemia: April 2007 to March 2020
  • MSSA bacteraemia: April 2011 to March 2020
  • E. coli bacteraemia: April 2012 to March 2020
  • Klebsiella spp. bacteraemia: April 2017 to March 2020
  • P. aeruginosa bacteraemia: April 2017 to March 2020
  • C. difficile infection: April 2007 to March 2020

Annual Trust and CCG tables

For annual publications for previous financial years please see:

Published 10 July 2014
Last updated 3 December 2020 + show all updates
  1. Added annual epidemiological commentary up to and including the financial year April 2019 to March 2020, archived April 2018 to March 2019 data.

  2. Added amended commentary with corrected values for age and sex rates and population in tables 28 and 29 on page 60.

  3. Added annual epidemiological commentary up to and including the financial year April 2018 to March 2019, archived April 2017 to March 2018 data.

  4. Archived all historic annual reports, added headline information link and updated the headline information for all data collections, for financial year 2017 to 2018, to correct data for hospital/community-onset comparisons.

  5. Added annual epidemiological commentary up to and including the financial year April 2017 to March 2018.

  6. Added annual epidemiological commentary up to and including the financial year April 2016 to March 2017.

  7. Added annual epidemiological commentary up to and including the financial year April 2015 to March 2016.

  8. Annual epidemiological commentary up to and including the financial year April 2014 to March 2015 added.

  9. First published.